Free Trial

Insider Selling: Scotts Miracle-Gro (NYSE:SMG) Director Sells $176,345.10 in Stock

Scotts Miracle-Gro logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Director David Evans sold 2,655 shares for about $176,345 at an average price of $66.42, reducing his direct stake by 9.46% to 25,405 shares.
  • Scotts Miracle-Gro reported quarterly adjusted results that beat estimates, with EPS of -$2.16 versus -$2.21 expected; revenue of $302.9 million fell short of forecasts and declined 10.9% year over year.
  • The company declared a quarterly dividend of $0.66 per share, equivalent to $2.64 annually and a 4.1% yield. Analysts’ average rating was “Moderate Buy,” with a $74.80 average price target.
  • Five stocks we like better than Scotts Miracle-Gro.

The Scotts Miracle-Gro Company (NYSE:SMG - Get Free Report) Director David Evans sold 2,655 shares of the business's stock in a transaction on Monday, November 9th. The stock was sold at an average price of $66.42, for a total transaction of $176,345.10. Following the transaction, the director directly owned 25,405 shares in the company, valued at $1,687,400.10. This trade represents a 9.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Scotts Miracle-Gro Price Performance

NYSE SMG opened at $64.95 on Thursday. The company's fifty day moving average is $56.01 and its two-hundred day moving average is $61.99. The Scotts Miracle-Gro Company has a 52-week low of $47.90 and a 52-week high of $75.34. The firm has a market capitalization of $3.78 billion, a price-to-earnings ratio of 38.66 and a beta of 1.87.

Scotts Miracle-Gro (NYSE:SMG - Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The basic materials company reported ($2.16) EPS for the quarter, beating analysts' consensus estimates of ($2.21) by $0.05. Scotts Miracle-Gro had a net margin of 3.16% and a negative return on equity of 77.42%. The business had revenue of $302.90 million during the quarter, compared to analyst estimates of $306.11 million. During the same quarter in the prior year, the business earned ($2.63) earnings per share. The firm's revenue for the quarter was down 10.9% on a year-over-year basis. As a group, sell-side analysts expect that The Scotts Miracle-Gro Company will post 4.78 earnings per share for the current fiscal year.

Scotts Miracle-Gro Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, November 20th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 4.1%. Scotts Miracle-Gro's payout ratio is currently 157.14%.

Analyst Ratings Changes

Several equities research analysts have issued reports on SMG shares. Wall Street Zen lowered shares of Scotts Miracle-Gro from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Citigroup reiterated an "overweight" rating on shares of Scotts Miracle-Gro in a research report on Monday, November 2nd. Weiss Ratings cut Scotts Miracle-Gro from a "hold (c)" rating to a "hold (c-)" rating in a report on Tuesday, October 6th. JPMorgan Chase & Co. dropped their target price on shares of Scotts Miracle-Gro from $70.00 to $67.00 and set a "neutral" rating for the company in a research report on Thursday, November 5th. Finally, Stifel Nicolaus lowered their target price on Scotts Miracle-Gro from $76.00 to $75.00 and set a "buy" rating for the company in a research note on Tuesday, September 29th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Scotts Miracle-Gro has an average rating of "Moderate Buy" and an average target price of $74.80.

View Our Latest Stock Report on Scotts Miracle-Gro

Institutional Trading of Scotts Miracle-Gro

Hedge funds and other institutional investors have recently made changes to their positions in the business. Kestrel Investment Management Corp acquired a new position in Scotts Miracle-Gro during the first quarter valued at approximately $2,390,000. Madison Asset Management LLC acquired a new position in shares of Scotts Miracle-Gro during the 2nd quarter worth approximately $7,163,000. Royal Bank of Canada grew its stake in shares of Scotts Miracle-Gro by 182.2% in the first quarter. Royal Bank of Canada now owns 66,698 shares of the basic materials company's stock valued at $4,057,000 after buying an additional 43,066 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Scotts Miracle-Gro in the second quarter valued at $1,323,000. Finally, Corient Private Wealth LP grew its stake in shares of Scotts Miracle-Gro by 500.3% in the second quarter. Corient Private Wealth LP now owns 114,728 shares of the basic materials company's stock valued at $7,814,000 after buying an additional 95,616 shares in the last quarter. 74.07% of the stock is currently owned by institutional investors and hedge funds.

Scotts Miracle-Gro Company Profile

(Get Free Report)

Scotts Miracle-Gro Company develops, manufactures and markets branded products for lawn care and gardening. Its offerings include grass seed, lawn fertilizers and weed-control products, soils, plant foods and other products for growing and maintaining lawns, gardens and landscapes. Its consumer brands include Scotts, Miracle-Gro and Ortho. The company also has a Hawthorne business that supplies equipment and products for indoor and hydroponic gardening. Scotts Miracle-Gro's products are sold primarily in North America, with additional operations and sales in international markets.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Scotts Miracle-Gro Right Now?

Before you consider Scotts Miracle-Gro, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scotts Miracle-Gro wasn't on the list.

While Scotts Miracle-Gro currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines